Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
grade D 64.16 1.94% 1.22
GKOS closed up 3.69 percent on Friday, August 16, 2019, on 85 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical GKOS trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 1.94%
Oversold Stochastic Weakness 1.94%
Calm After Storm Range Contraction 5.70%
Narrow Range Bar Range Contraction 5.70%
NR7 Range Contraction 5.70%
NR7-2 Range Contraction 5.70%
Wide Bands Range Expansion 5.70%
Oversold Stochastic Weakness 5.70%
Calm After Storm Range Contraction 6.01%
Narrow Range Bar Range Contraction 6.01%

Older signals for GKOS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.
Medicine Surgery Glaucoma Ophthalmology Implant Vision Blindness Drainage Incision Treatment Of Glaucoma Eye Surgery Pipeline Products Intraocular Pressure
Is GKOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 84.65
52 Week Low 39.88
Average Volume 452,989
200-Day Moving Average 68.1286
50-Day Moving Average 74.0934
20-Day Moving Average 72.0395
10-Day Moving Average 65.914
Average True Range 3.0157
ADX 30.24
+DI 16.618
-DI 39.0844
Chandelier Exit (Long, 3 ATRs ) 75.60290000000001
Chandelier Exit (Short, 3 ATRs ) 69.0471
Upper Bollinger Band 87.4933
Lower Bollinger Band 56.5857
Percent B (%b) 0.21
BandWidth 42.903685
MACD Line -3.8831
MACD Signal Line -2.2285
MACD Histogram -1.6545
Fundamentals Value
Market Cap 2.16 Billion
Num Shares 34.4 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -1573.50
Price-to-Sales 8.40
Price-to-Book 9.34
PEG Ratio -14.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 66.44
Resistance 3 (R3) 66.14 64.68 65.85
Resistance 2 (R2) 64.68 63.79 64.83 65.66
Resistance 1 (R1) 63.81 63.24 64.25 64.11 65.46
Pivot Point 62.35 62.35 62.57 62.50 62.35
Support 1 (S1) 61.48 61.46 61.92 61.78 60.42
Support 2 (S2) 60.02 60.91 60.17 60.22
Support 3 (S3) 59.15 60.02 60.03
Support 4 (S4) 59.45